We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regulatory News: Sensorion (FR0012596468 – ALSEN), société pionnière de biotechnologie au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et...
SENS-501 gene therapy product and surgical procedure are well tolerated by the first two treated patients and encouraging behavioural changes are observed in both toddlers Sensorion plans on...
Regulatory News: Sensorion (FR0012596468 – ALSEN), société pionnière de biotechnologie au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et...
Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within...
Regulatory News: Sensorion (FR0012596468 – ALSEN), société pionnière de biotechnologie au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.058 | -8.52941176471 | 0.68 | 0.684 | 0.61 | 20111 | 0.64712022 | DE |
4 | 0.004 | 0.647249190939 | 0.618 | 0.706 | 0.61 | 26257 | 0.67127326 | DE |
12 | -0.094 | -13.1284916201 | 0.716 | 0.77 | 0.584 | 32690 | 0.6735901 | DE |
26 | -0.036 | -5.47112462006 | 0.658 | 0.97 | 0.584 | 42301 | 0.7577581 | DE |
52 | 0.117 | 23.1683168317 | 0.505 | 1.04 | 0.505 | 61490 | 0.76405439 | DE |
156 | -0.184 | -22.8287841191 | 0.806 | 1.172 | 0.26 | 70679 | 0.62409982 | DE |
260 | -0.279 | -30.9655937847 | 0.901 | 2.88 | 0.26 | 85492 | 1.14341187 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions